PALM BEACH GARDENS, FL – Aurora Diagnostics, a diagnostic lab and anatomic pathology company, has filed for a $150 million initial public offering of stock.

We’ve noticed that diagnostics firms are on a roll this year. Several in the Southeast have made major acquisitions or landed funding. As we’ve pointed out in the past, an aging U.S. population has a lot to do with that, although other factors are also at play.

The company was founded in 2006 as a platform for the acquisition and integration of anatomic pathology and other diagnostic laboratory businesses. Aurora Diagnostics provides liquidity, financial upside, administrative resources, and accelerated growth opportunities to laboratory owners while allowing them to maintain their entrepreneurial approach and operational independence.

The company plans to trade on Nasdaq under the symbol “ARDX.”

The company also provides a bundle of services such as sales and marketing, information and medical technology, accounting and tax, risk management, managed care contracting and follow-on acquisitions to help laboratory owners perform their core business more efficiently and effectively.

It reported $171 million in net 2009 revenue, compared with $159 million in 2008 and net income of $9 million in 2009 vs. $10.7 million in 2008.

Southeast Venture Conference, February 29 – March 1, 2012 at the Ritz Carlton in Tysons Corner, VA – Where Smart Money Meets Smart People.
www.seventure.org

© 2010, TechJournal South. All rights reserved.

Tags: diagnostics, Florida, IPOs